Mentari Therapeutics(DE:MWG0)
€14.300.00 (0.00%)
DE:MWG0
Mentari Therapeutics financials statements
€14.30
At close:0.00 (0.00%)
Mentari Therapeutics (MWG0) Income Statement
1 Followers
Mentari Therapeutics Income Statement
Last quarter (Q1 2027), Mentari Therapeutics's total revenue was C$0.00, a decrease of 100.00% from the same quarter last year. In Q1, Mentari Therapeutics's net income was C$-2.33M. See Mentari Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| C$ 3.18B | C$ 4.94M | C$ 4.60M | C$ 4.14M | C$ 1.09M | |
| C$ 709.84M | C$ 1.71M | C$ 1.10M | C$ 1.40M | C$ 543.55K | |
| C$ 9.19M | C$ 9.62M | C$ 9.24M | C$ 9.78M | C$ 14.34M | |
| Depreciation and Amortization | C$ 708.36K | C$ 534.73K | C$ 604.52K | C$ 596.00K | C$ 511.79K |
| C$ -9.19M | C$ -7.26M | C$ -7.06M | C$ -7.34M | C$ -18.09M | |
| C$ -9.90M | C$ -7.92M | C$ -8.13M | C$ -8.38M | C$ -13.79M | |
| C$ -1.48M | C$ -244.14K | C$ 465.98K | C$ 444.26K | C$ -4.81M | |
| C$ -11.37M | C$ -8.16M | C$ -7.67M | C$ -7.93M | C$ -18.60M | |
| C$ -12.56M | C$ -8.16M | C$ -7.68M | C$ -7.95M | C$ -18.60M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -31.20 | C$ -83.60 | C$ -201.40 | C$ -649.20 | C$ -165820.00 |
| Diluted EPS | C$ -31.20 | C$ -83.60 | C$ -201.40 | C$ -649.20 | C$ -165820.00 |
| Weighted Average Shares Outstanding | 416.36K | 97.60K | 38.10K | 12.24K | 112 |
| Weighted Average Shares Outstanding (Diluted) | 416.36K | 97.60K | 38.10K | 12.24K | 112 |
Currency in CAD
